Enabling Medicare to negotiate drug prices is one of the most significant things we can do to make medicines affordable for patients and taxpayers, and must be part of any drug price reform. Similarly, lowering out-of-pocket costs and reining in drug corporations’ monopoly power to price-gouge through patent reforms are critical features of reform.